Business
WSJ News Exclusive | Bio-Rad Laboratories in Talks to Combine With Qiagen
[ad_1]
Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.
The talks have been going on for a while but any agreement isn’t likely for another few weeks or more—and there may not be one.
[ad_2]
